Access Pharmaceuticals Awarded Japan Patent for MuGard and ProctiGard
ACCESS PHARMACEUTICALS, INC., an emerging biopharmaceutical company, has received notification from the Japan Patent Office that a patent for MuGard and ProctiGard has been granted. The patent covers a wide range of liquid formulations for the prevention and treatment of mucosal diseases and disorders.
View full press release